Delivery Order SPE2DB22D3010-SPE2DB24FP1JE

Award Date 1/8/24
Potential Completion Date 1/9/24
Potential Value $5.6K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply NURTEC ODT 75 MG TABLET 8S with a potential value of $3,789.68. The delivery order has a completion date of January 23, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, has received multiple federal contract awards from DLA to provide pharmaceutical products and medical supplies in support of military...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply NURTEC ODT 75 MG TABLET 8S. The $5,684.52 contract has a completion date of January 4, 2024 and was awarded on January 3, 2024. No set-aside designation was used. AmerisourceBergen Drug Corp is a leading global pharmaceutical distribution company that has provided a range of pharmaceutical products and medical supplies...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply NURTEC ODT 75 MG TABLET 8S with a potential value of $9,222.19. The order has a completion date of December 28, 2023 and was awarded on December 27, 2023. Amerisourcebergen Drug Corp has an established history of providing pharmaceutical products and medical supplies to DLA Troop Support Medical facilities to support military...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NURTEC ODT 75 MG TABLET 8S. The $7,405.84 award has a completion date of December 20, 2023. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that has received multiple federal contract awards from DLA to supply pharmaceuticals, medical supplies, and related distribution services in support...
The U.S. Defense Logistics Agency (DLA) awarded a $18,445.91 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NURTEC ODT 75 MG TABLET 8S. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a ceiling value of $30,354.69. The order has an ultimate completion date of March 28, 2024. AmerisourceBergen Drug Corp, as the prime contractor, is the sole awardee of this delivery order, which is not associated with a set-aside program. The company has...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide NURTEC ODT 75 MG TABLET 8S. The $34,799.40 contract has a completion date of January 4, 2024 and does not have a set aside designation. AmerisourceBergen Drug Corp, as the prime contractor, will deliver the pharmaceutical product to support DLA Troop Support Medical facilities. AmerisourceBergen Corporation is a leading...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $4,582.84 contract is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. This delivery order was issued under an existing indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded solely to Amerisourcebergen Drug Corp, which serves...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NURTEC ODT 75 MG TABLET 8S for a ceiling value of $3,655.95. The contract has an ultimate completion date of April 2, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of NURTEC ODT 75 MG TABLET 8S medication. The contract has a completion date of February 2, 2024 and a potential value of $7,552.66. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
  • SPE2DB22D3010
    Indefinite Delivery Contract
  • SPE2DB22D3010-SPE2DB24FP1JE
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NURTEC ODT 75 MG TABLET 8S. The $5,623.64 order is part of Amerisourcebergen's larger indefinite delivery contract with DLA to supply pharmaceuticals and medical supplies in support of military treatment programs and facilities. The order has a completion date of January 9, 2024 and was awarded on January 8, 2024. No set-aside designation was used for this contract. Amerisourcebergen Drug Corp, as a prime contractor, has a history of providing a range of pharmaceutical and medical products to DLA and other government agencies.

Generated 4/8/24, 9:41 AM